Ibrutinib Approved in US for Rare LymphomaIbrutinib Approved in US for Rare Lymphoma

This is the first drug ever to be approved for the treatment of Waldenstrom's macroglobulinemia since the disease was described 70 years ago. FDA Approvals

Source: Medscape Hematology-Oncology Headlines - January 30, 2015 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news